Publicaciones en las que colabora con Alfredo Rodríguez Antolín (31)

2023

  1. Evaluation of Quality of Life and Self-reported Complications in Patients With Clean Intermittent Catheterization: An Observational Study

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, Vol. 50, Núm. 5, pp. 400-405

  2. Hormone sensitive protocol for metastatic prostate cancer, an update

    Actas Urologicas Espanolas, Vol. 47, Núm. 4, pp. 244-249

2022

  1. Corrigendum to <‘Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center’> <[Volume 40, Issue 7, July 2022, Pages 345.e19-345.e23]> (Urologic Oncology: Seminars and Original Investigations (2022) 40(7) (345.e19–345.e23), (S1078143922000679), (10.1016/j.urolonc.2022.02.018))

    Urologic Oncology: Seminars and Original Investigations

  2. Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center

    Urologic Oncology: Seminars and Original Investigations, Vol. 40, Núm. 7, pp. 345.e19-345.e23

  3. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

    World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004

2021

  1. Analgesic refractory colic pain: Is prolonged conservative management appropriate?

    American Journal of Emergency Medicine, Vol. 44, pp. 137-142

  2. Long surgical waiting list times are associated with an increased rate of negative ureteroscopies

    Canadian Urological Association Journal, Vol. 15, Núm. 12

  3. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia

    Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 1, pp. 76.e9-76.e14

2020

  1. Manejo de la hiperplasia benigna de próstata durante la pandemia COVID-19

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 405-412

2019

  1. Assessment of the influence of transrectal and transperineal prostate biopsies on erectile function: A prospective observational single-center study

    International Journal of Urology, Vol. 26, Núm. 11, pp. 1054-1058

  2. Cystoscopy Real-Time Self-Visualization and Its Impact in Patient's Pain Perception

    Journal of Endourology, Vol. 33, Núm. 4, pp. 309-313

  3. Factors Influencing Intraoperative Blood Loss in Patients Undergoing Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: A Large Multicenter Analysis

    Urology, Vol. 132, pp. 177-182

  4. Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain

    Actas Urologicas Espanolas, Vol. 43, Núm. 10, pp. 562-567

2018

  1. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies

    BJU International, Vol. 122, Núm. 6, pp. 1049-1065

  2. Radio-223 en la secuencia terapéutica del cáncer de próstata resistente a la castración metastásico

    Actas Urologicas Espanolas

  3. Supresión androgénica máxima con acetato de abiraterona en cáncer de próstata hormonosensible

    Archivos Espanoles de Urologia, Vol. 71, Núm. 3, pp. 267-275

2017

  1. Cáncer de próstata resistente a la castración. Recomendaciones de consenso de la Asociación Española de Urología

    Actas Urologicas Espanolas

  2. Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study – GESCAP group

    Actas Urologicas Espanolas, Vol. 41, Núm. 6, pp. 359-367

2016

  1. Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP

    Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216

2015

  1. Adherencia a las recomendaciones sobre la linfadenectomía de las guías clínicas del 2009 en el Registro Nacional de Cáncer de Próstata-2010

    Actas Urologicas Espanolas, Vol. 39, Núm. 9, pp. 546-552